Stay updated with breaking news from Nasdaq Plur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pluri (NASDAQ:PLUR – Get Free Report) and Tenaya Therapeutics (NASDAQ:TNYA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk. Insider & Institutional Ownership 16.6% of Pluri shares […]
Pluri to leverage its proprietary 3D technology platform to develop cell-based products for the coffee industry under its new business vertical...
Agreement signed following positive pre-clinical data demonstrating a one-time treatment with PLX-PAD significantly increased neurogenesis, offering...
Pluri (NASDAQ:PLUR – Get Free Report) and Ocugen (NASDAQ:OCGN – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings. Profitability This table compares Pluri and Ocugen’s net margins, […]
Pluri (NASDAQ:PLUR – Get Free Report) and Graphite Bio (NASDAQ:GRPH – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation. Analyst Ratings This is a breakdown of recent […]